Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.
about
Novel treatment approaches in hypertensive type 2 diabetic patientsFactors associated with utilization of dipeptidyl-4 inhibitors in patients with type 2 diabetes mellitus: a cross-sectional retrospective study.ß-blocker timolol prevents arrhythmogenic Ca²⁺ release and normalizes Ca²⁺ and Zn²⁺ dyshomeostasis in hyperglycemic rat heart.Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.Interaction of β1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signaling.Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.Novel insight into the dangerous connection between diabetes and heart failure.Carvedilol and antioxidant proteins in a type I diabetes animal model.Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress.Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes.
P2860
Q34023579-D503B4BB-5A77-425A-95DE-431F81BA9B12Q34203325-E9AA81FD-F2FD-4370-9554-26AF7898648EQ34907705-E8935422-9EB9-487B-99CE-746B88F2D126Q35557410-F155CF8F-DA1F-4F13-9455-F45858955D33Q36661845-9D1416ED-A1D0-4DAC-859B-F12CE09EB215Q38604382-01F076B9-B8B1-4A57-A07C-FB5C192BE880Q38806574-2A6011B5-BE50-42BD-9894-5CD82D63953AQ39224330-3C5FB75D-BB78-42D9-BA64-85375ABCCF48Q45338593-3B8BB135-0C9C-43D1-9CFB-4E0245C64D1AQ49418865-49A4E44D-AD45-4FF7-A322-679C08BB5BB8
P2860
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Beta blocker use in subjects w ...... not worsen glycaemic control.
@ast
Beta blocker use in subjects w ...... not worsen glycaemic control.
@en
type
label
Beta blocker use in subjects w ...... not worsen glycaemic control.
@ast
Beta blocker use in subjects w ...... not worsen glycaemic control.
@en
prefLabel
Beta blocker use in subjects w ...... not worsen glycaemic control.
@ast
Beta blocker use in subjects w ...... not worsen glycaemic control.
@en
P2093
P2860
P356
P1476
Beta blocker use in subjects w ...... not worsen glycaemic control.
@en
P2093
Leighton G Kearney
Louise M Burrell
Michelle Ord
P2860
P2888
P356
10.1186/1475-2840-11-14
P407
P577
2012-02-14T00:00:00Z
P5875
P6179
1002854855